Sector valuations Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:03 23/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 285.11 USD | +2.19% |
|
+4.48% | +42.93% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 77.93x | 4.52x | -0.35x | 4.02x | 15.62x | 19.16x | -.--% | 1.36TCr | ||
| 32.89x | 4.39x | 1.23x | 5.91x | 17.69x | 24.75x | 0.99% | 4.79TCr | ||
| 34.78x | 6.35x | -36.34x | 3.35x | 14.44x | 21.82x | -.--% | 4.45TCr | ||
| 48.22x | 8.16x | 0.24x | 5.6x | 30.63x | 35.25x | -.--% | 4.19TCr | ||
| -19.82x | 20.9x | -0.31x | 211.04x | -21.38x | -20.04x | -.--% | 4.13TCr | ||
| 27.01x | 2.19x | 0.55x | 7.79x | 20.05x | 23.49x | 0.42% | 3TCr | ||
| 35.84x | 25.71x | 2.38x | 5.89x | 26.75x | 27.98x | -.--% | 1.76TCr | ||
| 26.32x | 2.92x | 0.76x | 2.25x | 9.76x | 15.12x | 1.02% | 1.57TCr | ||
| -55.43x | 27.78x | 45.04x | 9.1x | 222.2x | -1689.64x | -.--% | 1.39TCr | ||
| 28.37x | 1.34x | 0.28x | 1.87x | 11.49x | 13.09x | -.--% | 1.29TCr | ||
| -431.29x | 2.82x | 4.53x | 13.23x | 78.58x | 102.81x | -.--% | 1.18TCr | ||
| 52.51x | 4.58x | 2.75x | 8.72x | 24.74x | 29.5x | 0.44% | 1.14TCr | ||
| 40.42x | 4.71x | 2.36x | 4.79x | 20.45x | 32.6x | 0.55% | 1.12TCr | ||
| -31.52x | 9.16x | -6.39x | 84.02x | -21.18x | -20.54x | -.--% | 1.01TCr | ||
| 31.19x | - | -0.1x | 16.32x | 29.78x | 29.09x | -.--% | 938.72Cr | ||
| 22.68x | 2.4x | -32.33x | 4.54x | 12.19x | 15.54x | 0.31% | 903.51Cr | ||
| -20.97x | 7.17x | 1.43x | 1760.59x | -22.54x | -22.96x | -.--% | 861.89Cr | ||
| -21.64x | 7.48x | -7.09x | 8946.23x | -17.67x | -17.4x | -.--% | 839.41Cr | ||
| 66.55x | 10.15x | 0.67x | - | - | - | - | 767.5Cr | ||
| Average | -2.95x | 8.49x | -1.09x | 616.40x | 25.09x | -76.69x | 0.21% | 1.93TCr | |
| Weighted average by Cap. | 8.53x | 8.90x | -3.14x | 282.86x | 21.81x | -47.60x | 0.25% |
Select your edition
All financial news and data tailored to specific country editions
















